Citation: Ej. Stanek et al., A CAUTION FOR MONTE-CARLO RISK ASSESSMENT OF LONG-TERM EXPOSURES BASED ON SHORT-TERM EXPOSURE STUDY DATA, Human and ecological risk assessment, 4(2), 1998, pp. 409-422
Authors:
STANEK EJ
CALABRESE EJ
MUNDT K
PEKOW P
YEATTS KB
Citation: Ej. Stanek et al., PREVALENCE OF SOIL MOUTHING INGESTION AMONG HEALTHY-CHILDREN AGED 1 TO 6/, Journal of soil contamination, 7(2), 1998, pp. 227-242
Authors:
JOHNSON HC
RENAUD EF
SCHMIDT DT
STANEK EJ
Citation: Hc. Johnson et al., SOCIAL-WORKERS VIEWS OF PARENTS OF CHILDREN WITH MENTAL AND EMOTIONALDISABILITIES, Families in society, 79(2), 1998, pp. 173-187
Citation: Gl. Earl et al., INTRAVENOUS NITROGLYCERIN TOLERANCE IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY AND CONGESTIVE-HEART-FAILURE, Pharmacotherapy, 18(1), 1998, pp. 203-209
Citation: Rj. Simko et Ej. Stanek, TREATMENT PATTERNS FOR HEART-FAILURE IN A PRIMARY-CARE ENVIRONMENT, American journal of managed care, 3(11), 1997, pp. 1669-1676
Citation: Ej. Calabrese et al., SOIL INGESTION RATES IN CHILDREN IDENTIFIED BY PARENTAL OBSERVATION AS LIKELY HIGH SOIL INGESTERS, Journal of soil contamination, 6(3), 1997, pp. 271-279
Authors:
CHENG JWM
CHARLAND SL
SHAW LM
KOBRIN S
GOLDFARB S
STANEK EJ
SPINLER SA
Citation: Jwm. Cheng et al., IS THE VOLUME OF DISTRIBUTION OF DIGOXIN REDUCED IN PATIENTS WITH RENAL DYSFUNCTION - DETERMINING DIGOXIN PHARMACOKINETICS BY FLUORESCENCE POLARIZATION IMMUNOASSAY, Pharmacotherapy, 17(3), 1997, pp. 584-590
Citation: Ej. Stanek et al., PROLONGED QUINIDINE HALF-LIFE WITH ASSOCIATED TOXICITY IN A PATIENT WITH HEPATIC-FAILURE, Pharmacotherapy, 17(3), 1997, pp. 622-625
Citation: Ej. Calabrese et al., METHODOLOGY TO ESTIMATE THE AMOUNT AND PARTICLE-SIZE OF SOIL INGESTEDBY CHILDREN - IMPLICATIONS FOR EXPOSURE ASSESSMENT AT WASTE SITES (VOL 24, PG 264, 1996), Regulatory toxicology and pharmacology, 25(1), 1997, pp. 87-87
Authors:
STANEK EJ
CHENG JWM
PEEPLES PJ
SIMKO RJ
SPINLER SA
Citation: Ej. Stanek et al., PATIENT PREFERENCES FOR THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION, Medical decision making, 17(4), 1997, pp. 464-471
Citation: Ej. Calabrese et al., SOIL INGESTION ESTIMATES FOR CHILDREN RESIDING ON A SUPERFUND SITE, Ecotoxicology and environmental safety, 36(3), 1997, pp. 258-268
Authors:
CALABRESE EJ
STANEK EJ
JAMES RC
ROBERTS SM
Citation: Ej. Calabrese et al., SOIL INGESTION - A CONCERN FOR ACUTE TOXICITY IN CHILDREN, Environmental health perspectives, 105(12), 1997, pp. 1354-1358
Authors:
HEBERT JR
MA YS
CLEMOW L
OCKENE IS
SAPERIA G
STANEK EJ
MERRIAM PA
OCKENE JK
Citation: Jr. Hebert et al., GENDER DIFFERENCES IN SOCIAL DESIRABILITY AND SOCIAL APPROVAL BIAS INDIETARY SELF-REPORT, American journal of epidemiology, 146(12), 1997, pp. 1046-1055
Authors:
HIRWAY PS
COOK JR
LEMESHOW S
STANEK EJ
KIRCHHOFFER JB
GIANELLY RE
Citation: Ps. Hirway et al., DESIGN AND TESTING OF A CONTINUOUS QUALITY INSTRUMENT FOR ELECTROCARDIOGRAPHIC INTERPRETATION, Journal of investigative medicine, 44(7), 1996, pp. 413-413
Citation: Ej. Stanek, ESTIMATING EXPOSURE DISTRIBUTIONS - A CAUTION FOR MONTE-CARLO RISK ASSESSMENT, Human and ecological risk assessment, 2(4), 1996, pp. 874-891
Citation: Ej. Calabrese et al., METHODOLOGY TO ESTIMATE THE AMOUNT AND PARTICLE-SIZE OF SOIL INGESTEDBY CHILDREN - IMPLICATIONS FOR EXPOSURE ASSESSMENT AT WASTE SITES, Regulatory toxicology and pharmacology, 24(3), 1996, pp. 264-268
Citation: Ej. Stanek et G. Pransky, UNILATERAL VS BILATERAL CARPAL-TUNNEL - CHALLENGES AND APPROACHES, American journal of industrial medicine, 29(6), 1996, pp. 669-678
Authors:
HIMMELSTEIN JS
FEUERSTEIN M
STANEK EJ
KOYAMATSU K
PRANSKY GS
MORGAN W
ANDERSON KO
Citation: Js. Himmelstein et al., WORK-RELATED UPPER-EXTREMITY DISORDERS AND WORK DISABILITY - CLINICALAND PSYCHOSOCIAL PRESENTATION, Journal of occupational and environmental medicine, 37(11), 1995, pp. 1278-1286
Citation: Ej. Stanek et al., XANTHINE INTERFERENCE WITH DIPYRIDAMOLE-THALLIUM-201 MYOCARDIAL IMAGING, The Annals of pharmacotherapy, 29(4), 1995, pp. 425-427
Citation: Rj. Simko et al., ACTIVATED CLOTTING TIME VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR THERAPEUTIC MONITORING OF HEPARIN, The Annals of pharmacotherapy, 29(10), 1995, pp. 1015-1021